Stock DZ
10.07.2018 kl 16:38
921

Liang!

In simple words: 10 BP chose to be anonymous because either:

- the research project has a substantial commercial value (FimaNacc has a wide spectrum of usage)

- the Big pharma is not yet well protected by patents for the research i.e competition.

Also big pharma usually discloses information in return of exclusive rights and to do this they need to pay.
Arkivert